UBX stock touches 52-week high at $2.02 amid market optimism
Unity Biotechnology Inc (NASDAQ:UBX) stock has reached a 52-week high, trading at $2.02, signaling a period of robust ...
Business Insider18d
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
today strengthened the executive leadership team with the appointment of Federico Grossi, M.D., Ph.D., as chief medical officer. Dr. Grossi brings a wealth of experience in clinical development ...
Nasdaq18d
Unity Biotechnology Names Federico Grossi Chief Medical Officer, Pre-market Stock Rises
(RTTNews) - Shares of Unity Biotechnology, Inc. (UBX) are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical Officer. Federico Grossi ...
UNITY Biotechnology Reports Granting of New Employment Inducement Award
NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that on January 6, 2025, the Compensation Committee of the Board of Directors ...
Investing18d
UNITY Biotech appoints new chief medical officer
SAN FRANCISCO - UNITY Biotechnology, Inc. [NASDAQ:UBX], a biotech firm focused on developing treatments for age-related diseases with a market capitalization of $21.57 million, announced today the ...